HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brian T Welsh Selected Research

apitegromab

7/2021Preclinical Safety Assessment and Toxicokinetics of Apitegromab, an Antibody Targeting Proforms of Myostatin for the Treatment of Muscle-Atrophying Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brian T Welsh Research Topics

Disease

1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
07/2021
1Cardiotoxicity
05/2021
1Neoplasms (Cancer)
05/2021
1Body Weight (Weight, Body)
11/2017
1Alzheimer Disease (Alzheimer's Disease)
06/2012

Drug/Important Bio-Agent (IBA)

1apitegromabIBA
07/2021
1Monoclonal AntibodiesIBA
05/2021
1SRK-181IBA
05/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
05/2021
1Protein Isoforms (Isoforms)IBA
05/2021
1Caffeine (No Doz)FDA LinkGeneric
11/2017
1Proteins (Proteins, Gene)FDA Link
06/2012
1Apolipoproteins E (ApoE)IBA
06/2012

Therapy/Procedure

1Immunotherapy
05/2021